1. Home
  2. SBFM vs FPAY Comparison

SBFM vs FPAY Comparison

Compare SBFM & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • FPAY
  • Stock Information
  • Founded
  • SBFM 2006
  • FPAY 2003
  • Country
  • SBFM United States
  • FPAY United States
  • Employees
  • SBFM N/A
  • FPAY N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • SBFM Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • SBFM Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • SBFM 6.7M
  • FPAY 27.2M
  • IPO Year
  • SBFM N/A
  • FPAY N/A
  • Fundamental
  • Price
  • SBFM $1.49
  • FPAY $1.04
  • Analyst Decision
  • SBFM Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • SBFM 1
  • FPAY 2
  • Target Price
  • SBFM $15.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • SBFM 184.9K
  • FPAY 86.5K
  • Earning Date
  • SBFM 08-15-2025
  • FPAY 08-05-2025
  • Dividend Yield
  • SBFM N/A
  • FPAY N/A
  • EPS Growth
  • SBFM N/A
  • FPAY N/A
  • EPS
  • SBFM N/A
  • FPAY N/A
  • Revenue
  • SBFM $36,234,578.00
  • FPAY $139,800,732.00
  • Revenue This Year
  • SBFM $192.48
  • FPAY $16.58
  • Revenue Next Year
  • SBFM N/A
  • FPAY N/A
  • P/E Ratio
  • SBFM N/A
  • FPAY N/A
  • Revenue Growth
  • SBFM 35.51
  • FPAY 19.51
  • 52 Week Low
  • SBFM $1.17
  • FPAY $0.84
  • 52 Week High
  • SBFM $6.99
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 48.64
  • FPAY 38.41
  • Support Level
  • SBFM $1.43
  • FPAY $0.84
  • Resistance Level
  • SBFM $1.61
  • FPAY $1.15
  • Average True Range (ATR)
  • SBFM 0.11
  • FPAY 0.09
  • MACD
  • SBFM 0.00
  • FPAY -0.01
  • Stochastic Oscillator
  • SBFM 27.78
  • FPAY 45.45

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: